Sorry Tangs but with the greatest of respect some of your points from an accounting point view do not stand up to scrutiny.
I like you am a shareholder and obviously enjoy a robust and improving share price for RMS.
But the fact is we have to look at the latest result in face, put all emotions to one side, and acknowledge the result was not good.
- Forums
- ASX - By Stock
- Ann: Ramelius H1 FY2019 Results
Sorry Tangs but with the greatest of respect some of your points...
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RMS (ASX) to my watchlist
(20min delay)
|
|||||
Last
$2.27 |
Change
-0.030(1.30%) |
Mkt cap ! $2.514B |
Open | High | Low | Value | Volume |
$2.27 | $2.29 | $2.22 | $7.884M | 3.493M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3771 | $2.26 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.28 | 319256 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 20000 | 0.865 |
3 | 71945 | 0.860 |
3 | 105645 | 0.855 |
8 | 349115 | 0.850 |
4 | 149449 | 0.845 |
Price($) | Vol. | No. |
---|---|---|
0.875 | 160614 | 9 |
0.880 | 267895 | 10 |
0.885 | 101645 | 5 |
0.890 | 131357 | 7 |
0.895 | 70000 | 2 |
Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
RMS (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
Previous Video
Next Video
SPONSORED BY The Market Online